BioMedSA New Members: November 2025

BioMedSA’s Board of Directors approved 5 new memberships in November 2025: BleedIO, ClearCam, DIRTT, Julie Riegel and QRx Partners.   BleedIO delivers SaaS and HaaS solutions using BLE Mesh, a wireless technology designed for decentralized networks that operate without internet or centralized systems. Proprietary technology improves uptime, resiliency, and security for IoT. Device-to-device (D2D) communication … Read more

BioMedSA Celebrates the Successful Launch of BioMarketSA

BioMedSA is thrilled to announce the successful launch of BioMarketSATM, an innovative program designed to accelerate the commercialization of healthcare and bioscience solutions. This initiative brought together 7 promising startups from across the country for an intensive bootcamp, culminating in mock pitch presentations to experienced members of Value Analysis Committees (VACs) at multiple hospitals—the very … Read more

Cost Savings: Business Management Solution

NetSuite seeks to help organizations increase productivity, improve efficiencies, and provide the visibility and control needed to run successful businesses by providing an integrated system that includes financials/Enterprise Resource Planning (ERP), inventory management, HR, professional services automation, and omnichannel commerce. With cross-industry expertise, NetSuite can be tailored to meet the specific needs of the industry … Read more

BioMedSA New Members: October 2025

BioMedSA’s Board of Directors approved 3 new memberships in October 2025: Cogent Consults, Nodon, and Oracle. Jeff Jung is a medtech commercialization veteran and founder of Cogent Consults, where he seeks to help startups and growth-stage companies strategize and execute to gain market adoption. He works with clients to develop Market Development Plans that go … Read more

Who’s Who in Central/South Texas – Luis Martinez-Sobrido, Ph.D.

Luis Martinez-Sobrido, Ph.D. is a globally recognized virologist whose groundbreaking research has significantly advanced our understanding of viral pathogenesis and vaccine development. He is especially known for his work on RNA viruses, including influenza, respiratory syncytial virus (RSV), and arenaviruses. His innovative use of reverse genetics systems has enabled the creation of recombinant viruses for … Read more

Cost Savings: Equipment Service

BioMedSA is part of a nationwide network of similar organizations who leverage their members’ purchasing volume to pre-negotiate cost savings contracts with key suppliers. These pre-negotiated contracts are available to BioMedSA members. We are pleased to introduce Specialty Underwrtiers Group (SU Group). SU Group specializes in consolidating multiple equipment service contracts into a single, easy-to-manage … Read more

Why Mobile and Modular Cleanrooms Are Changing the Game in Bio Manufacturing

In biomanufacturing, the ability to move fast and adapt isn’t just helpful—it’s survival. Yet traditional cleanrooms haven’t exactly kept up. They’re expensive, slow to build, and once they’re in place, they’re not going anywhere. That’s a big problem if your operation grows, pivots, or packs up and moves. Mobile and modular cleanrooms offer a smarter … Read more

BioMedSA Honors George B. Hernández, Jr. JD with the 2025 Innovation in Healthcare and Bioscience Lifetime Achievement Award

SAN ANTONIO (July 7, 2025) — Championing leadership in and advancement of the biomedical industry throughout the region, BioMedSA has selected George B. Hernández, Jr., JD, the visionary former President and CEO of University Health as its 2025 Innovation in Healthcare and Bioscience Lifetime Achievement Awardee. BioMedSA recognizes his decades-long commitment to public health, community … Read more

BioMedSA names 2025 Innovation in Healthcare and Bioscience Award Recipient

Texas Biomed President/CEO Dr. Larry Schlesinger honored for transformative approach to science and the business of science. SAN ANTONIO (June 2025) — Championing the biomedical industry and its contributions to the lives of the citizens of San Antonio, BioMedSA has selected its 2025 Innovation in Healthcare and Bioscience Awardee. BioMedSA named Texas Biomedical Research Institute … Read more

Sequence LifeScience, Inc Receives IRB Approval for a Novel Matched Controls Clinical Trial Targeting Diabetic Foot Ulcers (DFUs)

FOR IMMEDIATE RELASE Sequence LifeScience, Inc Receives IRB Approval for a Novel Matched Controls Clinical Trial Targeting Diabetic Foot Ulcers (DFUs) Groundbreaking study aims to improve healing outcomes and reduce complications for patients with chronic wounds. The study will also reduce the number of patients being randomized into control groups by utilizing historic controls data … Read more

Login

Welcome back! Login below